The benefit of combined nicorandil and colchicine therapy and associated Cx43 preservation in the PAH rat model [128] and attenuated PAH was recorded in this species due to the propylthiouracil thyroid-suppressing agent’s pleiotropic properties [129]. This evidence concerns the gene GJA1 and pulmonary arterial hypertension.